<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1798</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2024-32-s2-1195-1201</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>INNOVATIVE TECHNOLOGY FOR THE TREATMENT OF COGNITIVE DISORDERS</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Yakushin</surname><given-names>M. A.</given-names></name><email></email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/><xref ref-type="aff" rid="aff-3"/><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Karpova</surname><given-names>O. V.</given-names></name><email></email><xref ref-type="aff" rid="aff-3"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kabaeva</surname><given-names>E. N.</given-names></name><email></email><xref ref-type="aff" rid="aff-3"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Arseenkova</surname><given-names>O. Yu.</given-names></name><email></email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vorobeva</surname><given-names>A. V.</given-names></name><email></email><xref ref-type="aff" rid="aff-3"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gabrielyan</surname><given-names>A. R.</given-names></name><email></email><xref ref-type="aff" rid="aff-3"/><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department, 115088, Moscow, Russia</aff><aff id="aff-2"></aff><aff id="aff-3">N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia</aff><aff id="aff-4">State University of Education, 141014, Moscow, Russia</aff><pub-date date-type="epub" iso-8601-date="2024-11-08" publication-format="electronic"><day>08</day><month>11</month><year>2024</year></pub-date><volume>32</volume><fpage>1195</fpage><lpage>1201</lpage><history><pub-date date-type="received" iso-8601-date="2025-07-02"><day>02</day><month>07</month><year>2025</year></pub-date></history><permissions><copyright-statement>Copyright © 1970,</copyright-statement><copyright-year>1970</copyright-year></permissions><abstract>The authors digitized therapeutic factors used in the treatment of various forms of cognitive disorders, including dementia, with the subsequent development of a medical information system «Diagnosis and treatment of cognitive disorders». The medical information system «Diagnosis and treatment of cognitive disorders» was created on the basis of the 1C platform, supplemented by the module «Treatment of cognitive disorders», focused on supporting medical decision-making when choosing therapeutic factors for patients with cognitive disorders. It is planned to use this module in the complex activities of memory impairment classrooms.</abstract><kwd-group xml:lang="en"><kwd>cognitive disorders</kwd><kwd>dementia</kwd><kwd>memory impairment rooms</kwd><kwd>medical information system</kwd><kwd>dementia treatment</kwd><kwd>innovative treatment</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>когнитивные расстройства</kwd><kwd>деменция</kwd><kwd>кабинеты нарушения памяти</kwd><kwd>медицинская информационная система</kwd><kwd>лечение деменции</kwd><kwd>инновационное лечение</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Dementia Alzheimer Report 2018. The state of the art of dementia research: New frontiers. London; 2018. Р. 48.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Юдина В. В., Лукина Е. В., Макаров Н. С. и др. Деменция как проявление дегенеративных заболеваний нервной системы: дискуссионные вопросы патогенеза, перспективы лечения и профилактики // Лечащий врач. 2019. №10. С. 40—46. DOI: 10.26295/0S.2019.23.44.008</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Силькис И. Г. Возможные механизмы комплексного влияния ацетилхолина на тета-активность, обучение и память // Нейрохимия. 2019. Т. 36, №2. С. 101—118. DOI: 10.1134/S1027813319020110</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ващенко И. С., Соколов А. В., Чеботарева Е. Г. Современный взгляд на биохимические механизмы патогенеза альцгеймеровской нейродегенерации // Бюллетень медицинских интернет-конференций. 2013. Т. 3, №2. С. 120—122.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Емелин А. Ю., Лобзин В. Ю. Модифицированные критерии диагностики сосудистых когнитивных расстройств // Вестник Российской Военно-медицинской академии. 2020. S3. С. 25—28. DOI: 10.32863/1682-7392-2020-3-71-25-28</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kinnunen K. M., Vikhanova A., Livingston G. The management of sleep disorders in dementia: an update // Curr. Opin. Psychiatry. 2017. Vol. 30, N 6. P. 491—497. DOI: 10.1097/YCO.0000000000000370</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Ковальчук В. В. Когнитивная дисфункция. Современный взгляд на этиопатогенез, диагностику и терапию // Эффективная фармакотерапия. 2020. Т. 16, №31. С. 40—52. DOI: 10.33978/2307-3586-2020-16-31-40-52</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Левин О. С. Диагностика и лечение деменции в клинической практике. М.; 2010.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hartley L. Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases // Cochrane Database Syst Rev. 2013. Vol. 4, N 6. P. CD009874. DOI: 10.1002/14651858.CD009874.pub2</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>McShane R., Westby M. J., Roberts E. et al. Memantine for dementia // Cochrane Database Syst Rev. 2019. Vol. 3. P. CD003154. DOI: 10.1002/14651858.CD003154.pub6</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Cummings J., Lai T.-J., Hemrungrojn S. et al. Role of Donepezil in the management of neuropsychiatric symptoms in Alzheimer’s disease and dementia with Lewy bodies // CNS Neurosci. Ther. 2016. Vol. 22. P. 159—166. DOI: 10.1111/cns.12484</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Пизова Н. В. Когнитивные нарушения в детском возрасте при некоторых неврологических заболеваниях // Медицинский совет. 2012. №7. С. 86—91.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Risk reduction of cognitive decline and dementia: WHO guidelines. Geneva; 2019.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Williamson J. D., Pajewski N. M., Auchus A. P. Effect of intensive vs standard blood pressure control on probable dementia: A randomized clinical trial // JAMA. 2019. Vol. 321, N 6. P. 553—561. DOI: 10.1001/jama.2018.21442</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Singh B., Parsaik A. K., Mielke M. M. et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis // J. Alzheimers Dis. 2014. Vol. 39, N 2. P. 271—282. DOI: 10.3233/JAD-130830</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Song D., Yu D. S.F., Li P. W.C., Lei Y. The effectiveness of physical exercise on cognitive and psychological outcomes in individuals with mild cognitive impairment: A systematic review and meta-analysis // Int. J. Nurs. Stud. 2018. Vol. 79. P. 155—164. DOI: 10.1016/j.ijnurstu.2018.01.002</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Chandler M. J., Parks A. C., Marsiske M. et al. Everyday impact of cognitive interventions in mild cognitive impairment: a systematic review and meta-analysis // Neuropsychol. Rev. 2016. Vol. 26, N 3. P. 225—251. DOI: 10.1007/s11065-016-9330-4</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Kasper S., Bancher C., Eckert A. et al. Management of mild cognitive impairment (MCI): The need for national and international guidelines // World J. Biol. Psychiatry. 2020. Vol. 5. P. 1—16. DOI: 10.1080/15622975.2019</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Якушин М. А., Карпова О. В., Костров А. А. и др. Диагностика и лечение когнитивных расстройств // Свидетельство о регистрации программы для ЭВМ RU 2023666652, 02.08.2023. Заявка №2023666061 от 21.07.2023.</mixed-citation></ref></ref-list></back></article>
